$AGE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AgeX Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AgeX Therapeutics, Inc.. Get notifications about new insider transactions in AgeX Therapeutics, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2021 | AGE | AgeX Therapeutics, ... | Bailey Gregory | Director | Option Exercise | A | 1.48 | 65,000 | 96,200 | 65,000 | |
| Jun 23 2021 | AGE | AgeX Therapeutics, ... | Bailey Gregory | Director | Option Exercise | A | 1.48 | 65,000 | 96,200 | 65,000 | |
| Jun 08 2021 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | A | 1.45 | 120,000 | 174,000 | 120,000 | |
| Jun 08 2021 | AGE | AgeX Therapeutics, ... | SEGALL JUDITH | Director of Admin & ... | Option Exercise | A | 1.45 | 3,000 | 4,350 | 3,000 | |
| Jun 08 2021 | AGE | AgeX Therapeutics, ... | SEGALL JUDITH | Director of Admin & ... | Option Exercise | A | 1.45 | 3,000 | 4,350 | 3,000 | |
| Mar 15 2021 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 25,000 | |
| Mar 15 2021 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Payment of Exercise | F | 2.03 | 1,284 | 2,607 | 32,439 | 33.7 K to 32.4 K (-3.81 %) |
| Mar 15 2021 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | M | 0.00 | 3,125 | 0 | 33,723 | 30.6 K to 33.7 K (+10.21 %) |
| Jan 12 2021 | AGE | AgeX Therapeutics, ... | Juvenescence Ltd | 10% Owner | Option Exercise | P | 1.52 | 328,947 | 499,999 | 328,947 | |
| Dec 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 28,125 | |
| Dec 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Payment of Exercise | F | 1.69 | 1,081 | 1,827 | 30,598 | 31.7 K to 30.6 K (-3.41 %) |
| Dec 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | M | 0.00 | 3,125 | 0 | 31,679 | 28.6 K to 31.7 K (+10.94 %) |
| Dec 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 28,125 | |
| Dec 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Payment of Exercise | F | 1.69 | 1,081 | 1,827 | 30,598 | 31.7 K to 30.6 K (-3.41 %) |
| Dec 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | M | 0.00 | 3,125 | 0 | 31,679 | 28.6 K to 31.7 K (+10.94 %) |
| Nov 19 2020 | AGE | AgeX Therapeutics, ... | Juvenescence Ltd | 10% Owner | Option Exercise | P | 1.78 | 280,898 | 499,998 | 280,898 | |
| Oct 06 2020 | AGE | AgeX Therapeutics, ... | Juvenescence Ltd | 10% Owner | Option Exercise | P | 0.85 | 588,235 | 500,000 | 588,235 | |
| Sep 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 31,250 | |
| Sep 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Payment of Exercise | F | 0.81 | 1,081 | 875 | 28,554 | 29.6 K to 28.6 K (-3.65 %) |
| Sep 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | M | 0.00 | 3,125 | 0 | 29,635 | 26.5 K to 29.6 K (+11.79 %) |
| Jul 30 2020 | AGE | AgeX Therapeutics, ... | Juvenescence Ltd | 10% Owner | Option Exercise | P | 1.33 | 375,939 | 499,999 | 375,939 | |
| Jun 16 2020 | AGE | AgeX Therapeutics, ... | Juvenescence Ltd | 10% Owner | Option Exercise | P | 0.92 | 541,125 | 500,000 | 541,125 | |
| Jun 16 2020 | AGE | AgeX Therapeutics, ... | Juvenescence Ltd | 10% Owner | Option Exercise | P | 0.70 | 714,285 | 500,000 | 714,285 | |
| Jun 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 34,375 | |
| Jun 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Payment of Exercise | F | 0.80 | 1,081 | 865 | 26,510 | 27.6 K to 26.5 K (-3.92 %) |
| Jun 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | M | 0.00 | 3,125 | 0 | 27,591 | 24.5 K to 27.6 K (+12.77 %) |
| Jun 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 34,375 | |
| Jun 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Payment of Exercise | F | 0.80 | 1,081 | 865 | 26,510 | 27.6 K to 26.5 K (-3.92 %) |
| Jun 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | M | 0.00 | 3,125 | 0 | 27,591 | 24.5 K to 27.6 K (+12.77 %) |
| Apr 03 2020 | AGE | AgeX Therapeutics, ... | Juvenescence Ltd | 10% Owner | Option Exercise | P | 0.93 | 268,817 | 250,000 | 268,817 | |
| Mar 13 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | M | 0.00 | 12,500 | 0 | 37,500 | |
| Mar 13 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Payment of Exercise | F | 0.88 | 5,085 | 4,463 | 24,446 | 29.5 K to 24.4 K (-17.22 %) |
| Mar 13 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | M | 0.00 | 12,500 | 0 | 29,551 | 17.1 K to 29.6 K (+73.31 %) |
| Nov 21 2019 | AGE | AgeX Therapeutics, ... | SEGALL JUDITH | Director, Admin & S ... | Option Exercise | A | 1.44 | 15,000 | 21,600 | 15,000 | |
| Nov 21 2019 | AGE | AgeX Therapeutics, ... | SEGALL JUDITH | Director, Admin & S ... | Option Exercise | A | 1.44 | 15,000 | 21,600 | 15,000 | |
| Nov 21 2019 | AGE | AgeX Therapeutics, ... | SEGALL JUDITH | Director, Admin & S ... | Option Exercise | A | 1.44 | 15,000 | 21,600 | 15,000 | |
| Nov 21 2019 | AGE | AgeX Therapeutics, ... | SEGALL JUDITH | Director, Admin & S ... | Option Exercise | A | 1.44 | 15,000 | 21,600 | 15,000 | |
| Aug 15 2019 | AGE | AgeX Therapeutics, ... | Juvenescence Ltd | 10% Owner | Option Exercise | P | 2.60 | 150,000 | 390,000 | 150,000 | |
| Aug 15 2019 | AGE | AgeX Therapeutics, ... | Juvenescence Ltd | 10% Owner | Buy | P | 0.00 | 19,000 | 0 | 16,419,000 | 16.4 M to 16.4 M (+0.12 %) |
| Mar 20 2019 | AGE | AgeX Therapeutics, ... | MAULDIN JOHN F | Director | Option Exercise | S | 2.50 | 50,000 | 125,000 | 0 | |
| Mar 13 2019 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
| Mar 13 2019 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | A | 4.28 | 100,000 | 428,000 | 100,000 | |
| Mar 13 2019 | AGE | AgeX Therapeutics, ... | STERNBERG HAL | Vice President-Rese ... | Option Exercise | A | 4.28 | 15,000 | 64,200 | 15,000 | |
| Mar 13 2019 | AGE | AgeX Therapeutics, ... | Mulroy Michael H. | Director | Option Exercise | A | 4.28 | 65,000 | 278,200 | 65,000 | |
| Mar 13 2019 | AGE | AgeX Therapeutics, ... | MAULDIN JOHN F | Director | Option Exercise | A | 4.28 | 65,000 | 278,200 | 65,000 | |
| Mar 13 2019 | AGE | AgeX Therapeutics, ... | MALIK NAFEES NASEER | Chief Operating Off ... | Option Exercise | A | 4.28 | 70,000 | 299,600 | 70,000 | |
| Mar 13 2019 | AGE | AgeX Therapeutics, ... | Bailey Gregory | Director | Option Exercise | A | 4.28 | 100,000 | 428,000 | 100,000 | |
| Mar 13 2019 | AGE | AgeX Therapeutics, ... | Jenkins Annalisa | Director | Option Exercise | A | 4.28 | 100,000 | 428,000 | 100,000 | |
| Dec 12 2018 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | P | 3.86 | 4,000 | 15,443 | 15,460 | 11.5 K to 15.5 K (+34.90 %) |
Page: 1